Adverse reactions of intravenous immunoglobulin

Saudi Medical Journal

Volumn 21, Issue 10, 2000, Pages 953-956

  Al Wahadneh, Adel M ^a   Khriesat, Imad A ^a   Kuda, Emad H ^a  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

Adverse reaction; Intravenous immunoglobulin

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEADACHE; HEPATITIS B; HEPATITIS C; HOSPITAL PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFANT; INFUSION; MALE; NAUSEA; PRURITUS; SIDE EFFECT; SYNCOPE; TECHNIQUE; THORAX PAIN;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; CAUSALITY; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFECTION CONTROL; JORDAN; MALE; PATIENT SELECTION; PRIMARY PREVENTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0033773394     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Buckley RH. Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am 1994; 41: 665-690.
2. Roifman CM, Levision H, Gelfand EW. High-Dose versus Low-Dose intravenous Immunoglobulin in hypogammaglobulinemia and chronic luns disease. Lancet 1987; 9: 1075-1077.
3. Brennan VM, Cochrane S, Fletcher C, Hendy D, Powell P. Surveillance of adverse reactions in patients self-infusing intravenous Immunoglobulin at home. J Clin Immunol 1995; 15: 116-119.
4. Cochrane S. Care of patients undergoing Immunoglobulin therapy. Nurs Stand 1997; 11: 44-46.
5. Report of a WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol 1997; 109 (Suppl 1): 1-28.
6. Mtsbach SA, Chapel HM. Adverse effects of intravenous Immunoglobulin. Drug Saf 1993; 9: 254-262.
7. Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child 1998; 79: 48-51.
8. Mollnes TE, Harboe M. Recent advances: Clinical immunology. BMJ 1996; 312: 1465-1469.
9. Report from the European Group for Immunodefiencies (EGID). Intravenous gamma globulin for immunodefeciency. Clin Exp Immunol 1986; 65: 683-690.
10. Newburger JW, Takahashi M, Beiser A, Burns JC, Bastian J, Chung KJ et al. A single Intravenous Infusion of Gamma Globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-1991.
11. Rosenfeld EA, Shulman TS, Corydan KH, Mason W, Takahashi M, Kuroda C. Comparative safety and efficacy of two immunoglobulin products in Kawasaki disease. The Journal of Pediatrics 1995; 126: 1000-1003.
12. Newburger JW, Takahashi M, Burns JC, Beisar AS, Chung KJ, Duffy E et al. The treatment of Kawasaki syndrome with Intravenous Gamma Globulin. N Engl J Med 1986; 315: 341-346.
13. Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after Gamma Globulin administration in patients with hypogammaglobulinemia. N Engl J Med 1986; 14: 560-563.